University of Connecticut discusses antidiarrheal medication loperamide and its potential for abuse in patients self-treating opioid withdrawal symptoms or seeking euphoric effects with large doses. It is a growing problem, prompting the FDA to limit the number of doses in OTC packages.
Search
News Archives
News Signup
FREE: daily or weekly news supporting freedom from dependency
Journal signup
FREE: print journal and emag supporting freedom from dependency
Conference savings
MONEY OFF: for signups
Support our work
To support us giving the recovery field FREE daily news+research, FREE library, FREE journal and subsidised conference training, click the secure Donate link. THANK YOU!
Recent News
